UBS Group AG - LION BIOTECHNOLOGIES INC ownership

LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 82 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$186,000
-83.6%
25,000
-84.6%
0.00%
-100.0%
Q4 2016$1,131,000
-53.1%
162,770
-44.4%
0.00%0.0%
Q3 2016$2,412,000
+6.9%
293,008
+5.1%
0.00%0.0%
Q2 2016$2,257,000
+60.5%
278,706
+0.7%
0.00%0.0%
Q1 2016$1,406,000
-39.6%
276,715
-8.2%
0.00%
-50.0%
Q4 2015$2,326,000
+12.8%
301,319
-15.8%
0.00%
+100.0%
Q3 2015$2,062,000
-29.7%
358,000
+11.8%
0.00%
-50.0%
Q2 2015$2,935,000
+19.1%
320,100
+57.3%
0.00%0.0%
Q1 2015$2,464,000203,5000.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q1 2017
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 3,180,913$18,322,0004.76%
ACUTA CAPITAL PARTNERS, LLC 1,314,959$7,574,0004.38%
Perceptive Advisors 5,910,912$34,046,0001.36%
P.A.W. CAPITAL CORP 200,000$1,152,0001.32%
Ghost Tree Capital, LLC 300,000$1,728,0000.78%
Broadfin Capital, LLC 2,105,519$12,128,0000.68%
Rhenman & Partners Asset Management AB 683,108$3,935,0000.63%
Trellus Management Company, LLC 60,539$349,0000.51%
Cormorant Asset Management, LP 499,815$2,879,0000.46%
QVT Financial LP 1,433,700$8,258,0000.28%
View complete list of LION BIOTECHNOLOGIES INC shareholders